A detailed history of Canada Pension Plan Investment Board transactions in Immunovant, Inc. stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 1,200 shares of IMVT stock, worth $33,012. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,200
Previous 199,800 99.4%
Holding current value
$33,012
Previous $5.27 Million 99.37%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$27.51 - $27.51 $5.46 Million - $5.46 Million
-198,600 Reduced 99.4%
1,200 $33,000
Q2 2024

Aug 12, 2024

BUY
$25.1 - $31.61 $5.01 Million - $6.32 Million
199,800 New
199,800 $5.27 Million

Others Institutions Holding IMVT

About Immunovant, Inc.


  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.